Finnrick - Ensuring a Safer and More Transparent Supply Chain
Nexaph

Nexaph

Ipamorelin

Finnrick tested 4 samples of Ipamorelin (GHS agonist) from Nexaph between 3 Jul 2025 and 31 Oct 2025. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).

Finnrick Rating™
Tentative Rating
Nexaph
Ipamorelin
Tested 4 Samples
Last test 31 Oct 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Ipamorelin tests from top-rated vendors:

All Ipamorelin tests from Nexaph

Samples are tested in commercial labs

Tests Count

4

Scores

AVG3.0MIN0.0MAX6.2

Last

31 Oct 2025

First

3 Jul 2025
Quantity
Test DateCertificate
Test Score
Label
Batch
TestedDifferencePurityBatch IDContainerTested AtSent By
31 Oct 2025View0.010mg
⚠️ Sample does not contain Ipamorelin
(no batch ID)No Label / Silver Crimp / Clear Blue CapLab GPublic
30 Oct 2025View4.810mg
9.0mg
10.500mg+17.2%98.50%IPA1008282025-10No Label / Blue Crimp / Yellow CapLab GPublic
2 Oct 2025View1.010mg
⚠️ Sample does not contain Ipamorelin
Ht-08No Label / Silver Crimp / Blue Cap Lab GPublic
3 Jul 2025View6.210mg(no batch claim)9.730mg-2.7%98.18%IPA1004262025-08No Label / Purple Crimp / Green Cap Lab EPublic